for anyone who is looking for something new for small cell treatment vanderbilt university in nashville is going to be confirming the results of a previous study using cisplatin and camptosar to treat sclc.in the previous study the 2 year survival rate of patients using this went up to 18% compared to the 6% two year survival rate that physicians have been able to acheive using the standard chemo of etopside and cisplatin. If the results of this hold true that would triple the survival chances for anyone using it for sclc. I am posting this just for anyone who may be interested